Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Fund Raise

South West Pinnacle Exploration Fund Raise

South West Pinnacle Exploration Ltd confirmed there was no deviation in the utilization of proceeds from its February 2025 preferential issue of equity shares and warrants. The company remains compliant with Regulation 32 of SEBI (LODR) Regulations for the period ended March 31, 2026.

Source

BSE filing, NSE: SOUTHWEST. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

South West Pinnacle Exploration Ltd: key numbers

Share price
₹175.30
Market cap
₹572.4 Cr
Revenue (annual)
₹243.0 Cr
Net profit (annual)
₹33.03 Cr
P/E (TTM)
14.3×Sector 16.5×
Promoter holding
61.70%-3.11% QoQ
FII holding
0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from South West Pinnacle Exploration Ltd

All →

Other fund raise announcements

All →
20:28 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value
₹72.00 Cr
19:27 IST NSE
Fund RaiseFlywings Simulator Training Centre Ltd FWSTC

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value
₹68.20 Cr
16:20 IST BSE
Fund RaiseKanel Industries Ltd KANELOIL

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value
₹16.99 Cr
Execution
Rights issue opens 23 November 2026 and closes 30 November 2026
15:05 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.